nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Vemurafenib—melanoma	0.177	0.273	CbGbCtD
Indinavir—ABCB1—melanoma	0.172	1	CbGaD
Indinavir—ABCC1—Dactinomycin—melanoma	0.118	0.182	CbGbCtD
Indinavir—ABCC1—Docetaxel—melanoma	0.0607	0.0938	CbGbCtD
Indinavir—CYP3A4—Temozolomide—melanoma	0.0467	0.0722	CbGbCtD
Indinavir—ABCC2—Docetaxel—melanoma	0.0449	0.0695	CbGbCtD
Indinavir—CYP2D6—Vemurafenib—melanoma	0.0402	0.0622	CbGbCtD
Indinavir—CYP3A7—Docetaxel—melanoma	0.03	0.0464	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.03	0.0464	CbGbCtD
Indinavir—ABCB1—Dactinomycin—melanoma	0.0284	0.0439	CbGbCtD
Indinavir—CYP3A4—Vemurafenib—melanoma	0.0256	0.0395	CbGbCtD
Indinavir—CYP3A5—Docetaxel—melanoma	0.0225	0.0348	CbGbCtD
Indinavir—ABCB1—Docetaxel—melanoma	0.0146	0.0226	CbGbCtD
Indinavir—CYP3A4—Docetaxel—melanoma	0.00877	0.0136	CbGbCtD
Indinavir—Lopinavir—ABCB1—melanoma	0.000437	0.309	CrCbGaD
Indinavir—Neuropathy peripheral—Temozolomide—melanoma	0.000421	0.00323	CcSEcCtD
Indinavir—Swelling—Docetaxel—melanoma	0.00042	0.00323	CcSEcCtD
Indinavir—Urinary tract infection—Temozolomide—melanoma	0.000418	0.0032	CcSEcCtD
Indinavir—Hepatic failure—Docetaxel—melanoma	0.000412	0.00317	CcSEcCtD
Indinavir—Chills—Bleomycin—melanoma	0.00041	0.00315	CcSEcCtD
Indinavir—Hepatobiliary disease—Temozolomide—melanoma	0.000406	0.00312	CcSEcCtD
Indinavir—Nelfinavir—ABCB1—melanoma	0.000406	0.287	CrCbGaD
Indinavir—Alopecia—Bleomycin—melanoma	0.000404	0.0031	CcSEcCtD
Indinavir—Erythema multiforme—Dactinomycin—melanoma	0.000403	0.00309	CcSEcCtD
Indinavir—Sinusitis—Temozolomide—melanoma	0.000403	0.00309	CcSEcCtD
Indinavir—Haemoglobin—Carmustine—melanoma	0.000401	0.00308	CcSEcCtD
Indinavir—Haemorrhage—Carmustine—melanoma	0.000399	0.00306	CcSEcCtD
Indinavir—Hypoaesthesia—Carmustine—melanoma	0.000397	0.00305	CcSEcCtD
Indinavir—Flushing—Dactinomycin—melanoma	0.000396	0.00304	CcSEcCtD
Indinavir—Hypersensitivity—Vemurafenib—melanoma	0.000395	0.00303	CcSEcCtD
Indinavir—Connective tissue disorder—Carmustine—melanoma	0.000392	0.00301	CcSEcCtD
Indinavir—Renal impairment—Docetaxel—melanoma	0.00039	0.00299	CcSEcCtD
Indinavir—Haemoglobin—Temozolomide—melanoma	0.000388	0.00297	CcSEcCtD
Indinavir—Haemorrhage—Temozolomide—melanoma	0.000386	0.00296	CcSEcCtD
Indinavir—Hepatitis—Temozolomide—melanoma	0.000386	0.00296	CcSEcCtD
Indinavir—Asthenia—Vemurafenib—melanoma	0.000385	0.00295	CcSEcCtD
Indinavir—Hypoaesthesia—Temozolomide—melanoma	0.000384	0.00294	CcSEcCtD
Indinavir—Pharyngitis—Temozolomide—melanoma	0.000383	0.00294	CcSEcCtD
Indinavir—Chills—Dactinomycin—melanoma	0.000383	0.00294	CcSEcCtD
Indinavir—Urinary tract disorder—Temozolomide—melanoma	0.000381	0.00292	CcSEcCtD
Indinavir—Pruritus—Vemurafenib—melanoma	0.000379	0.00291	CcSEcCtD
Indinavir—Connective tissue disorder—Temozolomide—melanoma	0.000379	0.00291	CcSEcCtD
Indinavir—Urethral disorder—Temozolomide—melanoma	0.000378	0.0029	CcSEcCtD
Indinavir—Alopecia—Dactinomycin—melanoma	0.000377	0.00289	CcSEcCtD
Indinavir—Pain in extremity—Docetaxel—melanoma	0.000371	0.00285	CcSEcCtD
Indinavir—Flushing—Carmustine—melanoma	0.00037	0.00284	CcSEcCtD
Indinavir—Ill-defined disorder—Bleomycin—melanoma	0.000369	0.00283	CcSEcCtD
Indinavir—Anaemia—Bleomycin—melanoma	0.000368	0.00282	CcSEcCtD
Indinavir—Diarrhoea—Vemurafenib—melanoma	0.000367	0.00282	CcSEcCtD
Indinavir—Erythema multiforme—Temozolomide—melanoma	0.000365	0.0028	CcSEcCtD
Indinavir—Malaise—Bleomycin—melanoma	0.000359	0.00275	CcSEcCtD
Indinavir—Flushing—Temozolomide—melanoma	0.000358	0.00275	CcSEcCtD
Indinavir—Dizziness—Vemurafenib—melanoma	0.000354	0.00272	CcSEcCtD
Indinavir—Alopecia—Carmustine—melanoma	0.000353	0.00271	CcSEcCtD
Indinavir—Immune system disorder—Temozolomide—melanoma	0.000348	0.00267	CcSEcCtD
Indinavir—Malnutrition—Carmustine—melanoma	0.000347	0.00267	CcSEcCtD
Indinavir—Cough—Bleomycin—melanoma	0.000347	0.00267	CcSEcCtD
Indinavir—Chills—Temozolomide—melanoma	0.000346	0.00266	CcSEcCtD
Indinavir—Ill-defined disorder—Dactinomycin—melanoma	0.000344	0.00264	CcSEcCtD
Indinavir—Anaemia—Dactinomycin—melanoma	0.000343	0.00263	CcSEcCtD
Indinavir—Vomiting—Vemurafenib—melanoma	0.000341	0.00262	CcSEcCtD
Indinavir—Alopecia—Temozolomide—melanoma	0.000341	0.00262	CcSEcCtD
Indinavir—Dry skin—Docetaxel—melanoma	0.00034	0.00261	CcSEcCtD
Indinavir—Myalgia—Bleomycin—melanoma	0.000339	0.0026	CcSEcCtD
Indinavir—Chest pain—Bleomycin—melanoma	0.000339	0.0026	CcSEcCtD
Indinavir—Rash—Vemurafenib—melanoma	0.000338	0.00259	CcSEcCtD
Indinavir—Dermatitis—Vemurafenib—melanoma	0.000338	0.00259	CcSEcCtD
Indinavir—Back pain—Carmustine—melanoma	0.000336	0.00258	CcSEcCtD
Indinavir—Headache—Vemurafenib—melanoma	0.000336	0.00258	CcSEcCtD
Indinavir—Malnutrition—Temozolomide—melanoma	0.000336	0.00258	CcSEcCtD
Indinavir—Discomfort—Bleomycin—melanoma	0.000335	0.00257	CcSEcCtD
Indinavir—Malaise—Dactinomycin—melanoma	0.000335	0.00257	CcSEcCtD
Indinavir—Cramp muscle—Docetaxel—melanoma	0.000334	0.00256	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000334	0.00256	CcSEcCtD
Indinavir—Dysgeusia—Temozolomide—melanoma	0.000329	0.00252	CcSEcCtD
Indinavir—Vision blurred—Carmustine—melanoma	0.000327	0.00251	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Docetaxel—melanoma	0.000327	0.00251	CcSEcCtD
Indinavir—Tremor—Carmustine—melanoma	0.000325	0.0025	CcSEcCtD
Indinavir—Anaphylactic shock—Bleomycin—melanoma	0.000325	0.00249	CcSEcCtD
Indinavir—Oedema—Bleomycin—melanoma	0.000325	0.00249	CcSEcCtD
Indinavir—Back pain—Temozolomide—melanoma	0.000325	0.00249	CcSEcCtD
Indinavir—Anaemia—Carmustine—melanoma	0.000321	0.00246	CcSEcCtD
Indinavir—Agitation—Carmustine—melanoma	0.000319	0.00245	CcSEcCtD
Indinavir—Nausea—Vemurafenib—melanoma	0.000318	0.00244	CcSEcCtD
Indinavir—Thrombocytopenia—Bleomycin—melanoma	0.000318	0.00244	CcSEcCtD
Indinavir—Vision blurred—Temozolomide—melanoma	0.000316	0.00243	CcSEcCtD
Indinavir—Myalgia—Dactinomycin—melanoma	0.000316	0.00243	CcSEcCtD
Indinavir—Tremor—Temozolomide—melanoma	0.000315	0.00241	CcSEcCtD
Indinavir—Discomfort—Dactinomycin—melanoma	0.000312	0.0024	CcSEcCtD
Indinavir—Angina pectoris—Docetaxel—melanoma	0.000312	0.0024	CcSEcCtD
Indinavir—Ill-defined disorder—Temozolomide—melanoma	0.000311	0.00239	CcSEcCtD
Indinavir—Anaemia—Temozolomide—melanoma	0.00031	0.00238	CcSEcCtD
Indinavir—Anorexia—Bleomycin—melanoma	0.00031	0.00238	CcSEcCtD
Indinavir—Agitation—Temozolomide—melanoma	0.000308	0.00237	CcSEcCtD
Indinavir—Angioedema—Temozolomide—melanoma	0.000307	0.00235	CcSEcCtD
Indinavir—Oedema—Dactinomycin—melanoma	0.000303	0.00232	CcSEcCtD
Indinavir—Malaise—Temozolomide—melanoma	0.000303	0.00232	CcSEcCtD
Indinavir—Vertigo—Temozolomide—melanoma	0.000302	0.00231	CcSEcCtD
Indinavir—Palpitations—Temozolomide—melanoma	0.000297	0.00228	CcSEcCtD
Indinavir—Thrombocytopenia—Dactinomycin—melanoma	0.000297	0.00228	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000296	0.00227	CcSEcCtD
Indinavir—Chest pain—Carmustine—melanoma	0.000296	0.00227	CcSEcCtD
Indinavir—Myalgia—Carmustine—melanoma	0.000296	0.00227	CcSEcCtD
Indinavir—Anxiety—Carmustine—melanoma	0.000295	0.00226	CcSEcCtD
Indinavir—Cough—Temozolomide—melanoma	0.000293	0.00225	CcSEcCtD
Indinavir—Paraesthesia—Bleomycin—melanoma	0.000292	0.00224	CcSEcCtD
Indinavir—Saquinavir—ALB—melanoma	0.000292	0.206	CrCbGaD
Indinavir—Weight increased—Docetaxel—melanoma	0.000292	0.00224	CcSEcCtD
Indinavir—Dyspnoea—Bleomycin—melanoma	0.00029	0.00222	CcSEcCtD
Indinavir—Anorexia—Dactinomycin—melanoma	0.000289	0.00222	CcSEcCtD
Indinavir—Pneumonia—Docetaxel—melanoma	0.000287	0.00221	CcSEcCtD
Indinavir—Arthralgia—Temozolomide—melanoma	0.000286	0.00219	CcSEcCtD
Indinavir—Myalgia—Temozolomide—melanoma	0.000286	0.00219	CcSEcCtD
Indinavir—Anxiety—Temozolomide—melanoma	0.000285	0.00219	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000284	0.00218	CcSEcCtD
Indinavir—Oedema—Carmustine—melanoma	0.000283	0.00218	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000283	0.00217	CcSEcCtD
Indinavir—Discomfort—Temozolomide—melanoma	0.000282	0.00217	CcSEcCtD
Indinavir—Decreased appetite—Bleomycin—melanoma	0.000282	0.00217	CcSEcCtD
Indinavir—Acute coronary syndrome—Docetaxel—melanoma	0.000282	0.00216	CcSEcCtD
Indinavir—Renal failure—Docetaxel—melanoma	0.000281	0.00216	CcSEcCtD
Indinavir—Neuropathy peripheral—Docetaxel—melanoma	0.00028	0.00215	CcSEcCtD
Indinavir—Myocardial infarction—Docetaxel—melanoma	0.00028	0.00215	CcSEcCtD
Indinavir—Dry mouth—Temozolomide—melanoma	0.000279	0.00215	CcSEcCtD
Indinavir—Jaundice—Docetaxel—melanoma	0.000278	0.00214	CcSEcCtD
Indinavir—Saquinavir—ABCB1—melanoma	0.000278	0.197	CrCbGaD
Indinavir—Pain—Bleomycin—melanoma	0.000278	0.00213	CcSEcCtD
Indinavir—Thrombocytopenia—Carmustine—melanoma	0.000278	0.00213	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000276	0.00212	CcSEcCtD
Indinavir—Anaphylactic shock—Temozolomide—melanoma	0.000274	0.0021	CcSEcCtD
Indinavir—Oedema—Temozolomide—melanoma	0.000274	0.0021	CcSEcCtD
Indinavir—Anorexia—Carmustine—melanoma	0.00027	0.00207	CcSEcCtD
Indinavir—Hepatobiliary disease—Docetaxel—melanoma	0.00027	0.00207	CcSEcCtD
Indinavir—Nervous system disorder—Temozolomide—melanoma	0.000269	0.00206	CcSEcCtD
Indinavir—Thrombocytopenia—Temozolomide—melanoma	0.000268	0.00206	CcSEcCtD
Indinavir—Feeling abnormal—Bleomycin—melanoma	0.000268	0.00205	CcSEcCtD
Indinavir—Skin disorder—Temozolomide—melanoma	0.000266	0.00204	CcSEcCtD
Indinavir—Hyperhidrosis—Temozolomide—melanoma	0.000265	0.00203	CcSEcCtD
Indinavir—Decreased appetite—Dactinomycin—melanoma	0.000263	0.00202	CcSEcCtD
Indinavir—Fatigue—Dactinomycin—melanoma	0.000261	0.002	CcSEcCtD
Indinavir—Anorexia—Temozolomide—melanoma	0.000261	0.002	CcSEcCtD
Indinavir—Pain—Dactinomycin—melanoma	0.000259	0.00199	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Carmustine—melanoma	0.000258	0.00198	CcSEcCtD
Indinavir—Urticaria—Bleomycin—melanoma	0.000258	0.00198	CcSEcCtD
Indinavir—Haemoglobin—Docetaxel—melanoma	0.000258	0.00198	CcSEcCtD
Indinavir—Body temperature increased—Bleomycin—melanoma	0.000257	0.00197	CcSEcCtD
Indinavir—Haemorrhage—Docetaxel—melanoma	0.000256	0.00197	CcSEcCtD
Indinavir—Hepatitis—Docetaxel—melanoma	0.000256	0.00197	CcSEcCtD
Indinavir—Insomnia—Carmustine—melanoma	0.000256	0.00197	CcSEcCtD
Indinavir—Hypoaesthesia—Docetaxel—melanoma	0.000255	0.00196	CcSEcCtD
Indinavir—Paraesthesia—Carmustine—melanoma	0.000255	0.00195	CcSEcCtD
Indinavir—Pharyngitis—Docetaxel—melanoma	0.000255	0.00195	CcSEcCtD
Indinavir—Urinary tract disorder—Docetaxel—melanoma	0.000253	0.00194	CcSEcCtD
Indinavir—Dyspnoea—Carmustine—melanoma	0.000253	0.00194	CcSEcCtD
Indinavir—Somnolence—Carmustine—melanoma	0.000252	0.00193	CcSEcCtD
Indinavir—Connective tissue disorder—Docetaxel—melanoma	0.000252	0.00193	CcSEcCtD
Indinavir—Urethral disorder—Docetaxel—melanoma	0.000251	0.00193	CcSEcCtD
Indinavir—Feeling abnormal—Dactinomycin—melanoma	0.00025	0.00192	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Temozolomide—melanoma	0.00025	0.00192	CcSEcCtD
Indinavir—Insomnia—Temozolomide—melanoma	0.000248	0.0019	CcSEcCtD
Indinavir—Gastrointestinal pain—Dactinomycin—melanoma	0.000248	0.0019	CcSEcCtD
Indinavir—Decreased appetite—Carmustine—melanoma	0.000246	0.00189	CcSEcCtD
Indinavir—Paraesthesia—Temozolomide—melanoma	0.000246	0.00189	CcSEcCtD
Indinavir—Gastrointestinal disorder—Carmustine—melanoma	0.000245	0.00188	CcSEcCtD
Indinavir—Dyspnoea—Temozolomide—melanoma	0.000244	0.00187	CcSEcCtD
Indinavir—Somnolence—Temozolomide—melanoma	0.000244	0.00187	CcSEcCtD
Indinavir—Erythema multiforme—Docetaxel—melanoma	0.000242	0.00186	CcSEcCtD
Indinavir—Constipation—Carmustine—melanoma	0.000242	0.00186	CcSEcCtD
Indinavir—Pain—Carmustine—melanoma	0.000242	0.00186	CcSEcCtD
Indinavir—Dyspepsia—Temozolomide—melanoma	0.000241	0.00185	CcSEcCtD
Indinavir—Abdominal pain—Dactinomycin—melanoma	0.000239	0.00184	CcSEcCtD
Indinavir—Body temperature increased—Dactinomycin—melanoma	0.000239	0.00184	CcSEcCtD
Indinavir—Hypersensitivity—Bleomycin—melanoma	0.000239	0.00184	CcSEcCtD
Indinavir—Decreased appetite—Temozolomide—melanoma	0.000238	0.00183	CcSEcCtD
Indinavir—Flushing—Docetaxel—melanoma	0.000238	0.00183	CcSEcCtD
Indinavir—Gastrointestinal disorder—Temozolomide—melanoma	0.000237	0.00182	CcSEcCtD
Indinavir—Fatigue—Temozolomide—melanoma	0.000236	0.00181	CcSEcCtD
Indinavir—Pain—Temozolomide—melanoma	0.000234	0.0018	CcSEcCtD
Indinavir—Constipation—Temozolomide—melanoma	0.000234	0.0018	CcSEcCtD
Indinavir—Feeling abnormal—Carmustine—melanoma	0.000234	0.00179	CcSEcCtD
Indinavir—Asthenia—Bleomycin—melanoma	0.000233	0.00179	CcSEcCtD
Indinavir—Gastrointestinal pain—Carmustine—melanoma	0.000232	0.00178	CcSEcCtD
Indinavir—Immune system disorder—Docetaxel—melanoma	0.000232	0.00178	CcSEcCtD
Indinavir—Chills—Docetaxel—melanoma	0.00023	0.00177	CcSEcCtD
Indinavir—Pruritus—Bleomycin—melanoma	0.00023	0.00176	CcSEcCtD
Indinavir—Alopecia—Docetaxel—melanoma	0.000227	0.00174	CcSEcCtD
Indinavir—Feeling abnormal—Temozolomide—melanoma	0.000226	0.00173	CcSEcCtD
Indinavir—Abdominal pain—Carmustine—melanoma	0.000224	0.00172	CcSEcCtD
Indinavir—Body temperature increased—Carmustine—melanoma	0.000224	0.00172	CcSEcCtD
Indinavir—Gastrointestinal pain—Temozolomide—melanoma	0.000224	0.00172	CcSEcCtD
Indinavir—Malnutrition—Docetaxel—melanoma	0.000223	0.00171	CcSEcCtD
Indinavir—Hypersensitivity—Dactinomycin—melanoma	0.000223	0.00171	CcSEcCtD
Indinavir—Dysgeusia—Docetaxel—melanoma	0.000219	0.00168	CcSEcCtD
Indinavir—Urticaria—Temozolomide—melanoma	0.000218	0.00167	CcSEcCtD
Indinavir—Asthenia—Dactinomycin—melanoma	0.000217	0.00167	CcSEcCtD
Indinavir—Abdominal pain—Temozolomide—melanoma	0.000217	0.00166	CcSEcCtD
Indinavir—Body temperature increased—Temozolomide—melanoma	0.000217	0.00166	CcSEcCtD
Indinavir—Back pain—Docetaxel—melanoma	0.000216	0.00166	CcSEcCtD
Indinavir—Muscle spasms—Docetaxel—melanoma	0.000215	0.00165	CcSEcCtD
Indinavir—Hypersensitivity—Carmustine—melanoma	0.000209	0.0016	CcSEcCtD
Indinavir—Diarrhoea—Dactinomycin—melanoma	0.000207	0.00159	CcSEcCtD
Indinavir—Vomiting—Bleomycin—melanoma	0.000206	0.00158	CcSEcCtD
Indinavir—Anaemia—Docetaxel—melanoma	0.000206	0.00158	CcSEcCtD
Indinavir—Rash—Bleomycin—melanoma	0.000205	0.00157	CcSEcCtD
Indinavir—Dermatitis—Bleomycin—melanoma	0.000205	0.00157	CcSEcCtD
Indinavir—Asthenia—Carmustine—melanoma	0.000203	0.00156	CcSEcCtD
Indinavir—Hypersensitivity—Temozolomide—melanoma	0.000202	0.00155	CcSEcCtD
Indinavir—Syncope—Docetaxel—melanoma	0.0002	0.00154	CcSEcCtD
Indinavir—Palpitations—Docetaxel—melanoma	0.000197	0.00151	CcSEcCtD
Indinavir—Asthenia—Temozolomide—melanoma	0.000197	0.00151	CcSEcCtD
Indinavir—Loss of consciousness—Docetaxel—melanoma	0.000196	0.00151	CcSEcCtD
Indinavir—Cough—Docetaxel—melanoma	0.000195	0.0015	CcSEcCtD
Indinavir—Diarrhoea—Carmustine—melanoma	0.000194	0.00149	CcSEcCtD
Indinavir—Pruritus—Temozolomide—melanoma	0.000194	0.00149	CcSEcCtD
Indinavir—Nausea—Bleomycin—melanoma	0.000193	0.00148	CcSEcCtD
Indinavir—Vomiting—Dactinomycin—melanoma	0.000193	0.00148	CcSEcCtD
Indinavir—Rash—Dactinomycin—melanoma	0.000191	0.00147	CcSEcCtD
Indinavir—Chest pain—Docetaxel—melanoma	0.00019	0.00146	CcSEcCtD
Indinavir—Myalgia—Docetaxel—melanoma	0.00019	0.00146	CcSEcCtD
Indinavir—Arthralgia—Docetaxel—melanoma	0.00019	0.00146	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000189	0.00145	CcSEcCtD
Indinavir—Dizziness—Carmustine—melanoma	0.000187	0.00144	CcSEcCtD
Indinavir—Diarrhoea—Temozolomide—melanoma	0.000187	0.00144	CcSEcCtD
Indinavir—Dry mouth—Docetaxel—melanoma	0.000186	0.00143	CcSEcCtD
Indinavir—Oedema—Docetaxel—melanoma	0.000182	0.0014	CcSEcCtD
Indinavir—Anaphylactic shock—Docetaxel—melanoma	0.000182	0.0014	CcSEcCtD
Indinavir—Dizziness—Temozolomide—melanoma	0.000181	0.00139	CcSEcCtD
Indinavir—Vomiting—Carmustine—melanoma	0.00018	0.00138	CcSEcCtD
Indinavir—Nausea—Dactinomycin—melanoma	0.00018	0.00138	CcSEcCtD
Indinavir—Shock—Docetaxel—melanoma	0.000179	0.00138	CcSEcCtD
Indinavir—Rash—Carmustine—melanoma	0.000179	0.00137	CcSEcCtD
Indinavir—Nervous system disorder—Docetaxel—melanoma	0.000179	0.00137	CcSEcCtD
Indinavir—Dermatitis—Carmustine—melanoma	0.000179	0.00137	CcSEcCtD
Indinavir—Thrombocytopenia—Docetaxel—melanoma	0.000178	0.00137	CcSEcCtD
Indinavir—Headache—Carmustine—melanoma	0.000178	0.00136	CcSEcCtD
Indinavir—Skin disorder—Docetaxel—melanoma	0.000177	0.00136	CcSEcCtD
Indinavir—Vomiting—Temozolomide—melanoma	0.000174	0.00134	CcSEcCtD
Indinavir—Anorexia—Docetaxel—melanoma	0.000174	0.00133	CcSEcCtD
Indinavir—Rash—Temozolomide—melanoma	0.000173	0.00133	CcSEcCtD
Indinavir—Dermatitis—Temozolomide—melanoma	0.000173	0.00132	CcSEcCtD
Indinavir—Headache—Temozolomide—melanoma	0.000172	0.00132	CcSEcCtD
Indinavir—Nausea—Carmustine—melanoma	0.000168	0.00129	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000166	0.00127	CcSEcCtD
Indinavir—Insomnia—Docetaxel—melanoma	0.000165	0.00126	CcSEcCtD
Indinavir—Paraesthesia—Docetaxel—melanoma	0.000164	0.00126	CcSEcCtD
Indinavir—Nausea—Temozolomide—melanoma	0.000163	0.00125	CcSEcCtD
Indinavir—Dyspnoea—Docetaxel—melanoma	0.000162	0.00125	CcSEcCtD
Indinavir—Somnolence—Docetaxel—melanoma	0.000162	0.00124	CcSEcCtD
Indinavir—Dyspepsia—Docetaxel—melanoma	0.00016	0.00123	CcSEcCtD
Indinavir—Decreased appetite—Docetaxel—melanoma	0.000158	0.00122	CcSEcCtD
Indinavir—Gastrointestinal disorder—Docetaxel—melanoma	0.000157	0.00121	CcSEcCtD
Indinavir—Fatigue—Docetaxel—melanoma	0.000157	0.00121	CcSEcCtD
Indinavir—Constipation—Docetaxel—melanoma	0.000156	0.0012	CcSEcCtD
Indinavir—Pain—Docetaxel—melanoma	0.000156	0.0012	CcSEcCtD
Indinavir—Feeling abnormal—Docetaxel—melanoma	0.00015	0.00115	CcSEcCtD
Indinavir—Gastrointestinal pain—Docetaxel—melanoma	0.000149	0.00114	CcSEcCtD
Indinavir—Abdominal pain—Docetaxel—melanoma	0.000144	0.00111	CcSEcCtD
Indinavir—Body temperature increased—Docetaxel—melanoma	0.000144	0.00111	CcSEcCtD
Indinavir—Hypersensitivity—Docetaxel—melanoma	0.000134	0.00103	CcSEcCtD
Indinavir—Asthenia—Docetaxel—melanoma	0.000131	0.001	CcSEcCtD
Indinavir—Pruritus—Docetaxel—melanoma	0.000129	0.000989	CcSEcCtD
Indinavir—Diarrhoea—Docetaxel—melanoma	0.000125	0.000957	CcSEcCtD
Indinavir—Dizziness—Docetaxel—melanoma	0.00012	0.000925	CcSEcCtD
Indinavir—Vomiting—Docetaxel—melanoma	0.000116	0.000889	CcSEcCtD
Indinavir—Rash—Docetaxel—melanoma	0.000115	0.000882	CcSEcCtD
Indinavir—Dermatitis—Docetaxel—melanoma	0.000115	0.000881	CcSEcCtD
Indinavir—Headache—Docetaxel—melanoma	0.000114	0.000876	CcSEcCtD
Indinavir—Nausea—Docetaxel—melanoma	0.000108	0.000831	CcSEcCtD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.09e-05	0.000218	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.09e-05	0.000218	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP1B1—melanoma	1.08e-05	0.000216	CbGpPWpGaD
Indinavir—ABCC1—Disease—HIF1A—melanoma	1.07e-05	0.000214	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ABCB1—melanoma	1.04e-05	0.000209	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.04e-05	0.000207	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.03e-05	0.000206	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PLA2G6—melanoma	1.02e-05	0.000204	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PRKCA—melanoma	1.01e-05	0.000202	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ERCC2—melanoma	1e-05	0.0002	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP17A1—melanoma	9.97e-06	0.0002	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PLA2G6—melanoma	9.92e-06	0.000199	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLCB4—melanoma	9.8e-06	0.000196	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOS2—melanoma	9.74e-06	0.000195	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOTCH1—melanoma	9.64e-06	0.000193	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PRKCA—melanoma	9.58e-06	0.000192	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ABCB1—melanoma	9.56e-06	0.000191	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ERCC2—melanoma	9.5e-06	0.00019	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD80—melanoma	9.45e-06	0.000189	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	9.44e-06	0.000189	CbGpPWpGaD
Indinavir—ABCC1—Disease—APC—melanoma	9.43e-06	0.000189	CbGpPWpGaD
Indinavir—ABCC1—Disease—KIT—melanoma	9.43e-06	0.000189	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GNA11—melanoma	9.41e-06	0.000189	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PLA2G6—melanoma	9.35e-06	0.000187	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGF—melanoma	9.32e-06	0.000187	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PLA2G6—melanoma	9.27e-06	0.000186	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIP4K2A—melanoma	9.21e-06	0.000184	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC6A11—melanoma	9.21e-06	0.000184	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—FASN—melanoma	9.21e-06	0.000184	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.21e-06	0.000184	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—VCAN—melanoma	9.13e-06	0.000183	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.13e-06	0.000183	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—SLC5A5—melanoma	9.06e-06	0.000181	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTAP—melanoma	8.96e-06	0.000179	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—VCAN—melanoma	8.91e-06	0.000179	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ABCB1—melanoma	8.89e-06	0.000178	CbGpPWpGaD
Indinavir—ABCC1—Disease—BRAF—melanoma	8.86e-06	0.000178	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PRKCA—melanoma	8.79e-06	0.000176	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CG—melanoma	8.78e-06	0.000176	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CD44—melanoma	8.75e-06	0.000175	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GNAQ—melanoma	8.75e-06	0.000175	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ERCC2—melanoma	8.72e-06	0.000175	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.64e-06	0.000173	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARG—melanoma	8.47e-06	0.00017	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—VCAN—melanoma	8.4e-06	0.000168	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1B1—melanoma	8.39e-06	0.000168	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAP2K1—melanoma	8.35e-06	0.000167	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.34e-06	0.000167	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—VCAN—melanoma	8.33e-06	0.000167	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CD—melanoma	8.29e-06	0.000166	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.28e-06	0.000166	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PRKCA—melanoma	8.18e-06	0.000164	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ERCC2—melanoma	8.12e-06	0.000163	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LUM—melanoma	7.99e-06	0.00016	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PHGDH—melanoma	7.99e-06	0.00016	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGF2—melanoma	7.94e-06	0.000159	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—melanoma	7.9e-06	0.000158	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.88e-06	0.000158	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.87e-06	0.000158	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HPSE—melanoma	7.83e-06	0.000157	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CD—melanoma	7.72e-06	0.000155	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.71e-06	0.000154	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP17A1—melanoma	7.7e-06	0.000154	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CUBN—melanoma	7.69e-06	0.000154	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARG—melanoma	7.62e-06	0.000153	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—melanoma	7.62e-06	0.000153	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.61e-06	0.000152	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.6e-06	0.000152	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP17A1—melanoma	7.52e-06	0.000151	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—melanoma	7.51e-06	0.00015	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.5e-06	0.00015	CbGpPWpGaD
Indinavir—ABCC1—Disease—MDM2—melanoma	7.43e-06	0.000149	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SDHD—melanoma	7.42e-06	0.000149	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CSPG4—melanoma	7.42e-06	0.000149	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BSG—melanoma	7.42e-06	0.000149	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—melanoma	7.32e-06	0.000147	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GNA11—melanoma	7.28e-06	0.000146	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARG—melanoma	7.24e-06	0.000145	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CB—melanoma	7.23e-06	0.000145	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD4—melanoma	7.21e-06	0.000144	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPAM—melanoma	7.19e-06	0.000144	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—melanoma	7.16e-06	0.000143	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—FASN—melanoma	7.12e-06	0.000143	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GNA11—melanoma	7.1e-06	0.000142	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP17A1—melanoma	7.09e-06	0.000142	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP17A1—melanoma	7.03e-06	0.000141	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SLC5A5—melanoma	7e-06	0.00014	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.96e-06	0.000139	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—FASN—melanoma	6.95e-06	0.000139	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CD—melanoma	6.94e-06	0.000139	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.93e-06	0.000139	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCB1—melanoma	6.91e-06	0.000138	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—melanoma	6.89e-06	0.000138	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—melanoma	6.85e-06	0.000137	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.84e-06	0.000137	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC5A5—melanoma	6.84e-06	0.000137	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1B—melanoma	6.78e-06	0.000136	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GNAQ—melanoma	6.76e-06	0.000135	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CD44—melanoma	6.76e-06	0.000135	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CB—melanoma	6.73e-06	0.000135	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GNA11—melanoma	6.69e-06	0.000134	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—melanoma	6.66e-06	0.000133	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—melanoma	6.65e-06	0.000133	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GNA11—melanoma	6.63e-06	0.000133	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.62e-06	0.000133	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CD44—melanoma	6.6e-06	0.000132	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GNAQ—melanoma	6.6e-06	0.000132	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CD—melanoma	6.6e-06	0.000132	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.56e-06	0.000131	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—FASN—melanoma	6.55e-06	0.000131	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—melanoma	6.51e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—FASN—melanoma	6.49e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1B1—melanoma	6.49e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC5A5—melanoma	6.44e-06	0.000129	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—melanoma	6.41e-06	0.000128	CbGpPWpGaD
Indinavir—ABCC1—Disease—CTNNB1—melanoma	6.41e-06	0.000128	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC5A5—melanoma	6.39e-06	0.000128	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PRKCA—melanoma	6.36e-06	0.000127	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1B1—melanoma	6.33e-06	0.000127	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ERCC2—melanoma	6.3e-06	0.000126	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—melanoma	6.26e-06	0.000125	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—melanoma	6.24e-06	0.000125	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CD44—melanoma	6.22e-06	0.000125	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GNAQ—melanoma	6.22e-06	0.000125	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—melanoma	6.19e-06	0.000124	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CD44—melanoma	6.17e-06	0.000124	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GNAQ—melanoma	6.17e-06	0.000124	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLA2G6—melanoma	6.11e-06	0.000122	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—melanoma	6.06e-06	0.000121	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—melanoma	6.05e-06	0.000121	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.04e-06	0.000121	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—melanoma	6e-06	0.00012	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.98e-06	0.00012	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—melanoma	5.98e-06	0.00012	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1B1—melanoma	5.96e-06	0.000119	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1B1—melanoma	5.91e-06	0.000118	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—melanoma	5.81e-06	0.000116	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—melanoma	5.75e-06	0.000115	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.72e-06	0.000115	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—melanoma	5.7e-06	0.000114	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—melanoma	5.64e-06	0.000113	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—melanoma	5.58e-06	0.000112	CbGpPWpGaD
Indinavir—ABCC1—Disease—NRAS—melanoma	5.57e-06	0.000112	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—melanoma	5.56e-06	0.000111	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—VCAN—melanoma	5.49e-06	0.00011	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCB1—melanoma	5.34e-06	0.000107	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK3—melanoma	5.34e-06	0.000107	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—melanoma	5.28e-06	0.000106	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—melanoma	5.23e-06	0.000105	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—melanoma	5.23e-06	0.000105	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.22e-06	0.000105	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—melanoma	5.19e-06	0.000104	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK1—melanoma	5.08e-06	0.000102	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—melanoma	5.08e-06	0.000102	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—melanoma	4.98e-06	9.97e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—melanoma	4.97e-06	9.96e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PRKCA—melanoma	4.91e-06	9.85e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—melanoma	4.91e-06	9.84e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCB1—melanoma	4.91e-06	9.84e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ERCC2—melanoma	4.87e-06	9.76e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCB1—melanoma	4.87e-06	9.75e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—melanoma	4.87e-06	9.75e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—melanoma	4.81e-06	9.63e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PRKCA—melanoma	4.8e-06	9.61e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—melanoma	4.79e-06	9.6e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ERCC2—melanoma	4.76e-06	9.53e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP17A1—melanoma	4.63e-06	9.28e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—melanoma	4.56e-06	9.14e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PRKCA—melanoma	4.52e-06	9.06e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ERCC2—melanoma	4.48e-06	8.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PRKCA—melanoma	4.48e-06	8.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ERCC2—melanoma	4.44e-06	8.9e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—melanoma	4.41e-06	8.82e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—melanoma	4.38e-06	8.77e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GNA11—melanoma	4.38e-06	8.76e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—melanoma	4.32e-06	8.66e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—FASN—melanoma	4.28e-06	8.58e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—melanoma	4.24e-06	8.5e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC5A5—melanoma	4.21e-06	8.44e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—melanoma	4.1e-06	8.21e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—melanoma	4.08e-06	8.16e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GNAQ—melanoma	4.07e-06	8.15e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CD44—melanoma	4.07e-06	8.15e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.04e-06	8.09e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—melanoma	3.9e-06	7.81e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1B1—melanoma	3.9e-06	7.81e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—melanoma	3.85e-06	7.71e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—melanoma	3.82e-06	7.64e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—melanoma	3.78e-06	7.57e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—melanoma	3.76e-06	7.53e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—melanoma	3.72e-06	7.44e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—melanoma	3.69e-06	7.39e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.68e-06	7.37e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—melanoma	3.63e-06	7.26e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—melanoma	3.6e-06	7.21e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—melanoma	3.54e-06	7.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—melanoma	3.51e-06	7.03e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—melanoma	3.51e-06	7.02e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—melanoma	3.42e-06	6.85e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—melanoma	3.39e-06	6.79e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—melanoma	3.38e-06	6.78e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—melanoma	3.35e-06	6.71e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—melanoma	3.34e-06	6.69e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—melanoma	3.3e-06	6.62e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—melanoma	3.3e-06	6.6e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—melanoma	3.26e-06	6.53e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—melanoma	3.22e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCB1—melanoma	3.21e-06	6.43e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—melanoma	3.11e-06	6.24e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—melanoma	3.09e-06	6.18e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—melanoma	3.07e-06	6.16e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—melanoma	3.05e-06	6.1e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—melanoma	3.01e-06	6.04e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—melanoma	2.99e-06	6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PRKCA—melanoma	2.96e-06	5.92e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—melanoma	2.95e-06	5.91e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ERCC2—melanoma	2.93e-06	5.87e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—melanoma	2.92e-06	5.85e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—melanoma	2.88e-06	5.77e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—melanoma	2.86e-06	5.74e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—melanoma	2.85e-06	5.71e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—melanoma	2.71e-06	5.43e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—melanoma	2.69e-06	5.39e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—melanoma	2.69e-06	5.39e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—melanoma	2.66e-06	5.34e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—melanoma	2.63e-06	5.27e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—melanoma	2.55e-06	5.11e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—melanoma	2.49e-06	4.98e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—melanoma	2.45e-06	4.9e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—melanoma	2.34e-06	4.7e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—melanoma	2.33e-06	4.66e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—melanoma	2.32e-06	4.66e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—melanoma	2.31e-06	4.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—melanoma	2.23e-06	4.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—melanoma	2.04e-06	4.08e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—melanoma	2.01e-06	4.02e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—melanoma	1.9e-06	3.81e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—melanoma	1.8e-06	3.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—melanoma	1.77e-06	3.55e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—melanoma	1.76e-06	3.52e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—melanoma	1.76e-06	3.52e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—melanoma	1.65e-06	3.31e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—melanoma	1.64e-06	3.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—melanoma	1.53e-06	3.07e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—melanoma	1.47e-06	2.94e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—melanoma	1.43e-06	2.87e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—melanoma	1.35e-06	2.71e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—melanoma	1.34e-06	2.68e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—melanoma	1.08e-06	2.17e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—melanoma	8.83e-07	1.77e-05	CbGpPWpGaD
